Standout Papers
- Use of the Pfizer Respiratory Syncytial Virus Vaccine During Pregnancy for the Prevention of Respiratory Syncytial Virus–Associated Lower Respiratory Tract Disease in Infants: Recommendations of the Advisory Committee on Immunization Practices — United States, 2023 (2023)
- Use of Nirsevimab for the Prevention of Respiratory Syncytial Virus Disease Among Infants and Young Children: Recommendations of the Advisory Committee on Immunization Practices — United States, 2023 (2023)
- Use of COVID-19 Vaccines for Persons Aged ≥6 Months: Recommendations of the Advisory Committee on Immunization Practices — United States, 2024–2025 (2024)
Citation Impact
20 standout
Citing Papers
mRNA vaccines for infectious diseases — advances, challenges and opportunities
2024 Standout
Early Estimates of Updated 2023–2024 (Monovalent XBB.1.5) COVID-19 Vaccine Effectiveness Against Symptomatic SARS-CoV-2 Infection Attributable to Co-Circulating Omicron Variants Among Immunocompetent Adults — Increasing Community Access to Testing Program, United States, September 2023–January 2024
2024 Standout
Works of Oliver Brooks being referenced
Interim Recommendations from the Advisory Committee on Immunization Practices for the Use of Bivalent Booster Doses of COVID-19 Vaccines — United States, October 2022
2022
The Advisory Committee on Immunization Practices’ Interim Recommendation for Use of Pfizer-BioNTech COVID-19 Vaccine in Children Aged 5–11 Years — United States, November 2021
2021
Author Peers
| Author | Infectious Diseases | Health | Epidemiology | Last Decade | Papers | Cites |
|---|---|---|---|---|---|---|
| Oliver Brooks | 288 | 165 | 286 | 16 | 557 | |
| P. Lomellini | 15 | 388 | ||||
| Mei‐Ju Shih | 9 | 25 | 16 | 12 | 302 | |
| Sergey Eyderman | 14 | 388 | ||||
| Vladimir Mastyugin | 17 | 12 | 421 | |||
| Santina Bertone | 6 | 30 | 197 |
All Works
Loading papers...